The active ingredient in Salvia miltiorrhiza (Salviaric acid B) was shown to potentiate CD8+ T cell infiltration in the TME to increase the efficacy of anti-PD-L1 mAb in a breast cancer animal model, which was also accompanied by an endothelial protective effect and normalization of vascular function [217]. This evidence concerns the gene CD274 and breast carcinoma.